Guide to paying a small fine and making billions
by Jon Rappoport
July 30, 2017
The key factor is: be a drug company.
In this case, Celgene. Their drugs are Thalomid and Revlimid. They are approved for multiple myeloma, one type of cancer.
Here’s the thing. Doctors can decide to prescribe drugs for uses which are not approved by the FDA, but the manufacturers can’t promote those “off-label” uses to doctors. That’s illegal.
A long-running suit against Celgene, launched by Beverly Brown, who used to be the company’s sales manager, contends that:
Celgene trained its sales team to promote off-label uses to doctors;
Celgene sales people intentionally lied about studies, claiming the studies showed the off-label uses were beneficial to patients;
And the company omitted vital warnings about the drugs’ uses from the drugs’ labels.
Back in 2014, the judge in the case, George King, slammed Celgene for trying to…
View original post 814 more words